Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Pain Patch Market, by Distribution Channel
1.4.2 Asia Pacific Pain Patch Market, by Type
1.4.3 Asia Pacific Pain Patch Market, by Product Type
1.4.4 Asia Pacific Pain Patch Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Pain Patch Market by Distribution Channel
3.1 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
3.2 Asia Pacific Hospital Pharmacies Market by Country
3.3 Asia Pacific Online Providers Market by Country
Chapter 4. Asia Pacific Pain Patch Market by Type
4.1 Asia Pacific Prescription Medicines Market by Country
4.2 Asia Pacific OTC Medicines Market by Country
Chapter 5. Asia Pacific Pain Patch Market by Product Type
5.1 Asia Pacific Non-Opioid Patches Market by Country
5.2 Asia Pacific Pain Patch Market by Non-Opioid Patches Type
5.2.1 Asia Pacific Nonsteroidal Anti-Inflammatory Drugs Market by Country
5.2.2 Asia Pacific Methyl Salicylate Market by Country
5.2.3 Asia Pacific Lidocaine Market by Country
5.2.4 Asia Pacific Others Market by Country
5.3 Asia Pacific Opioid Patches Market by Country
Chapter 6. Asia Pacific Pain Patch Market by Country
6.1 China Pain Patch Market
6.1.1 China Pain Patch Market by Distribution Channel
6.1.2 China Pain Patch Market by Type
6.1.3 China Pain Patch Market by Product Type
6.1.3.1 China Pain Patch Market by Non-Opioid Patches Type
6.2 Japan Pain Patch Market
6.2.1 Japan Pain Patch Market by Distribution Channel
6.2.2 Japan Pain Patch Market by Type
6.2.3 Japan Pain Patch Market by Product Type
6.2.3.1 Japan Pain Patch Market by Non-Opioid Patches Type
6.3 India Pain Patch Market
6.3.1 India Pain Patch Market by Distribution Channel
6.3.2 India Pain Patch Market by Type
6.3.3 India Pain Patch Market by Product Type
6.3.3.1 India Pain Patch Market by Non-Opioid Patches Type
6.4 South Korea Pain Patch Market
6.4.1 South Korea Pain Patch Market by Distribution Channel
6.4.2 South Korea Pain Patch Market by Type
6.4.3 South Korea Pain Patch Market by Product Type
6.4.3.1 South Korea Pain Patch Market by Non-Opioid Patches Type
6.5 Singapore Pain Patch Market
6.5.1 Singapore Pain Patch Market by Distribution Channel
6.5.2 Singapore Pain Patch Market by Type
6.5.3 Singapore Pain Patch Market by Product Type
6.5.3.1 Singapore Pain Patch Market by Non-Opioid Patches Type
6.6 Malaysia Pain Patch Market
6.6.1 Malaysia Pain Patch Market by Distribution Channel
6.6.2 Malaysia Pain Patch Market by Type
6.6.3 Malaysia Pain Patch Market by Product Type
6.6.3.1 Malaysia Pain Patch Market by Non-Opioid Patches Type
6.7 Rest of Asia Pacific Pain Patch Market
6.7.1 Rest of Asia Pacific Pain Patch Market by Distribution Channel
6.7.2 Rest of Asia Pacific Pain Patch Market by Type
6.7.3 Rest of Asia Pacific Pain Patch Market by Product Type
6.7.3.1 Rest of Asia Pacific Pain Patch Market by Non-Opioid Patches Type
Chapter 7. Company Profiles
7.1 NEXGEL, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Research & Development Expenses
7.2 Viatris, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development Expense
7.3 Johnson & Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 SWOT Analysis
7.4 Teva Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Product Launches and Product Expansions:
7.5 Grünenthal GmbH
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Approvals & Trials:
7.6 Sorrento Therapeutics, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.6.4 Research & Development Expenses
7.7 Hisamitsu Pharmaceutical Co. Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Recent strategies and developments:
7.7.3.1 Product Launches and Product Expansions:
7.8 Endo International PLC
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expense
7.9 Purdue Pharma L.P.
7.9.1 Company Overview
7.10. Amneal Pharmaceuticals, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Partnerships, Collaborations, and Agreements:
7.10.5.1 Approvals & Trials:
Unique Offerings 